Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

After Delpharm bought the Boucherville plant in 2022, Sandoz signed an exclusive partnership with the company to maintain its ...

In the quiet corners of his room, where sunlight danced through the blinds and curiosity hummed softly, a young boy held a guitar as if it were a secret. Fingers stumbled over strings, awkward and ...

The next wave of multibaggers in India is likely to come from sectors benefiting from structural tailwinds, policy support, ...

Trump nominates John Squires as Director of the USPTO; former USPTO Solicitor Farheena Rasheed to the PTAB as Vice Chief; ...

To revive Tamil Nadu’s maritime heritage and position the state as a global hub for shipbuilding, the Finance Minister ...

CT-P13, intravenous infliximab, developed and manufactured by Celltrion, is the first monoclonal antibody biosimilar therapy and has been the most established biosimilar treatment in the Canadian mark ...

SAN FRANCISCO — Art Schallock, a left-handed pitcher who in 1951 replaced future Hall of Famer Mickey Mantle on the Yankees' roster and had been the oldest living former major leaguer ...

A panelist discusses how managing biosimilars requires close collaboration between payers and health systems to optimize patient care and cost savings, while sharing insights about program ...

Since the FDA’s groundbreaking approval of Zarxio in 2015, the US biosimilars market has surged to 67 approvals across 18 originators—though the journey has been anything but smooth, with adoption ...